EGFRExon 19 Insertions: Do Patients Respond to Tyrosine Kinase Inhibitor Treatment?

Epidermal growth factor receptor (EGFR) exon 19 insertions are very rare mutations and their response to tyrosine kinase inhibitors (TKIs) is uncertain. We report our experience concerning two patients, along with a literature review.